background
inappropri
high
level
antibiot
still
prescrib
primari
health
care
respiratori
tract
infect
rti
access
diagnost
pointofcar
test
poct
rti
might
reduc
overprescript
object
purpos
studi
determin
diagnost
perform
clinic
feasibl
recent
develop
diagnost
poct
respiratori
virus
maripoc
dutch
primari
healthcar
set
method
patient
rti
symptom
present
famili
practic
winter
season
determin
test
sensit
specif
rel
polymeras
chain
reaction
pcr
test
perform
laboratori
clinic
feasibl
poct
evalu
interview
gener
practition
gp
result
one
respiratori
virus
detect
patient
n
influenza
viru
n
sensit
poct
specif
influenza
b
viru
n
sensit
specif
respiratori
syncyti
viru
rsv
n
sensit
specif
sampl
higher
viral
load
sensit
influenza
influenza
b
rsv
avail
diagnost
test
respiratori
virus
appreci
patient
gp
conclus
studi
show
diagnost
poct
respiratori
virus
might
contribut
precis
evidencebas
diagnosi
rti
could
posit
influenc
prescript
antibiot
gp
howev
implement
primari
healthcar
diagnost
accuraci
poct
need
improv
impact
clinic
decis
make
assess
inappropri
use
antibiot
contribut
antimicrobi
resist
increas
health
care
cost
expos
patient
unnecessari
risk
advers
drug
event
vast
major
antibiot
prescrib
primari
care
respiratori
tract
infect
rti
frequent
indic
prescript
although
mani
clinic
guidelin
recommend
restrict
use
antibiot
rti
mainli
viral
origin
despit
intervent
reduc
overus
antibiot
introduct
clinic
guidelin
creactiv
protein
crp
test
patient
doctor
educ
inappropri
high
level
antibiot
still
prescrib
access
pointofcar
test
poct
guid
prescript
might
reduc
overprescript
antibiot
primari
care
poct
rapid
easytous
test
carri
near
patient
nonlaboratorytrain
personnel
benefit
poct
use
help
physician
manag
patient
expect
antibiot
encourag
patient
selfcar
suffer
selflimit
condit
moment
gener
practition
gp
mani
countri
access
poct
nonspecif
biomark
crp
cell
count
although
test
demonstr
effect
antibiot
prescript
recent
studi
suggest
test
biomark
virus
might
reduc
prescript
rate
therefor
new
poct
accur
detect
pathogen
associ
rti
requir
date
maripoc
produc
arcdia
intern
oy
ltd
turku
finland
multianalyt
rapid
diagnost
test
avail
suitabl
pointofcar
assay
primari
care
poct
previous
evalu
yet
test
nearpati
assay
famili
practic
purpos
studi
therefor
determin
diagnost
perform
clinic
feasibl
poct
dutch
primari
healthcar
set
research
question
follow
maripoc
perform
detect
respiratori
virus
patient
rti
symptom
use
maripoc
poct
gp
patient
satisfi
perform
easeofus
test
order
answer
question
prospect
analys
clinic
characterist
patient
children
adult
present
rti
symptom
gp
singl
practic
winter
season
determin
whether
patient
respiratori
viru
use
poct
refer
test
laboratori
oper
multiplex
polymeras
chain
reaction
pcr
test
calcul
sensit
specif
posit
neg
predict
valu
ppv
npv
poct
interview
doctor
ad
valu
poct
primari
health
care
prospect
studi
conduct
famili
practic
neighbourhood
academ
medic
center
amc
amsterdam
netherland
novemb
march
famili
practic
serv
approxim
patient
employ
seven
gp
famili
practic
one
larger
practic
netherland
cooper
partner
within
scientif
network
fifteen
year
allow
optim
patient
inclus
studi
logist
patient
age
underli
ill
medic
condit
present
gp
rti
symptom
regular
open
hour
famili
practic
elig
inclus
patient
need
least
two
respiratori
symptom
eg
cough
rhinorrhoea
headach
myalgia
wheez
fever
defin
purpos
studi
measur
ear
thermomet
less
day
give
written
inform
consent
patient
ask
fill
questionnair
demograph
clinic
background
symptom
undergo
posterior
nasopharyng
swab
sampl
swab
immedi
test
primari
health
care
practic
use
poct
member
studi
team
prior
start
studi
studi
team
member
receiv
hour
train
manufactur
use
test
remain
sampl
solut
transfer
day
laboratori
clinic
virolog
amc
refer
test
multiplex
pcr
pcr
consid
gold
standard
respiratori
viru
detect
studi
approv
medic
ethic
committe
amc
inform
consent
obtain
patient
parent
caregiv
enrol
children
provid
assent
age
appropri
maripoc
autom
pointofcar
compat
antigen
test
detect
nine
respiratori
virus
influenza
viru
type
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
type
human
metapneumoviru
hmpv
human
bocaviru
hbov
adenoviru
streptococcu
pneumonia
singl
nasopharyng
sampl
arcdia
intern
ltd
turku
finland
detect
antigen
base
separationfre
two
photon
excit
fluorometri
signal
respons
techniqu
directli
proport
analyt
concentr
sampl
ad
sampl
buffer
swab
sampl
sampl
insert
analys
preliminari
result
automat
report
minut
medium
high
posit
sampl
hour
final
result
automat
display
comput
new
sampl
insert
analysi
given
time
studi
final
maripoc
result
compar
refer
method
pneumonia
result
includ
studi
previous
describ
multiplex
pcr
use
test
respiratori
sampl
presenc
respiratori
virus
influenza
viru
type
b
rsv
piv
type
hmpv
hbov
adenoviru
rhinoviru
human
coronaviru
hcov
enteroviru
ev
human
parechoviru
hpev
threshold
cycl
ct
valu
consid
neg
studi
particip
ask
opinion
avail
rapid
test
respiratori
virus
primari
care
scale
follow
four
option
useless
opinion
valuabl
valuabl
end
studi
period
gp
interview
feasibl
poct
primari
care
structur
interview
base
standard
questionnair
cover
follow
topic
advantag
disadvantag
poct
addit
valu
poct
famili
practic
influenc
poct
prescript
antivir
medic
antibiot
addit
test
patient
satisfact
calcul
minim
number
patient
need
inclus
perform
sampl
size
calcul
assum
sampl
size
calcul
sensit
test
least
two
import
virus
influenza
rsv
decid
limit
inform
avail
differ
popul
test
previous
evalu
choos
precis
express
maximum
width
confid
interv
sensit
estim
preval
influenza
rsv
least
patient
includ
data
analys
use
spss
statist
softwar
version
spp
inc
chicago
il
sensit
specif
posit
neg
predict
valu
confid
interv
ci
calcul
viru
separ
reader
poct
refer
standard
blind
result
test
clinic
inform
avail
assessor
refer
standard
twosid
pvalu
consid
statist
signific
data
analysi
infect
consid
statist
independ
tabl
median
age
patient
year
interquartil
rang
iqr
year
rang
year
younger
year
age
femal
sixtyfour
patient
report
underli
condit
frequent
ill
respiratori
tract
eg
asthma
copd
vaccin
statu
avail
patient
receiv
annual
influenza
vaccin
cough
frequent
report
symptom
follow
rhinorrhoea
headach
sampl
one
respiratori
virus
detect
pcr
poct
one
respiratori
virus
detect
sampl
distribut
respiratori
virus
detect
pcr
poct
shown
tabl
total
two
sampl
posit
two
virus
poct
eight
sampl
posit
two
virus
pcr
none
sampl
posit
two
virus
specif
ci
rsv
n
sensit
ci
specif
ci
due
small
number
infect
piv
type
hmpv
hbov
adv
possibl
determin
sensit
poct
virus
specif
calcul
virus
result
specif
ci
ci
ci
ci
piv
hmpv
hbov
adv
respect
pcr
techniqu
gener
result
term
cycl
threshold
ct
valu
wellestablish
semiquantit
estim
viral
load
patient
ask
opinion
avail
rapid
diagnost
test
respiratori
virus
visit
gp
respiratori
symptom
result
avail
patient
patient
n
posit
test
n
consid
valuabl
addit
primari
care
n
consid
valuabl
addit
case
respiratori
viru
detect
poct
patient
report
confid
selflimit
aspect
ill
interview
five
gp
consid
poct
help
tool
convinc
patient
viral
diagnosi
five
thought
would
influenc
antibiot
prescript
behaviour
regular
open
hour
also
outofhour
depart
accord
gp
referr
hospit
would
influenc
poct
often
base
clinic
symptom
etiolog
diagnosi
gp
thought
implement
poct
primari
health
care
would
increas
patient
satisfact
might
contribut
patient
expect
selfmanag
possibl
influenc
inappropri
referr
decreas
addit
test
extra
visit
disadvantag
poct
extra
cost
time
interv
final
test
result
report
requir
chang
work
flow
accord
personnel
perform
poct
test
rapid
easytous
studi
evalu
first
time
diagnost
perform
clinic
feasibl
autom
rapid
test
respiratori
virus
pointofcar
primari
health
care
set
netherland
result
studi
suggest
set
dutch
famili
practic
poct
specif
detect
respiratori
virus
patient
respiratori
tract
symptom
sensit
lower
expect
fact
one
respiratori
virus
detect
pcr
patient
studi
indic
half
patient
present
gp
respiratori
tract
symptom
inde
viral
infect
find
rhinoviru
influenza
viru
frequent
detect
virus
line
epidemiolog
respiratori
virus
primari
care
report
studi
term
diagnost
perform
poct
report
sensit
influenza
viru
influenza
b
viru
rsv
lower
report
previou
studi
evalu
poct
like
due
patient
sampl
lower
viral
load
patient
studi
factor
thata
demonstr
herereduc
sensit
poct
three
main
factor
might
influenc
lower
viral
load
sampl
thu
lower
sensit
firstli
studi
popul
consist
mainli
adult
studi
poct
mainli
conduct
children
children
often
higher
viral
load
explain
better
result
antigen
detect
test
secondli
previou
studi
done
patient
hospit
present
outpati
depart
evalu
poct
primari
care
patient
tend
less
sever
ill
hospit
studi
suggest
diseas
sever
correl
posit
viral
load
thirdli
mani
patient
studi
visit
gp
almost
week
symptom
start
data
shown
antigen
test
design
detect
pathogen
acut
stage
infect
first
day
symptom
onset
sinc
viral
load
highest
despit
sensit
maripoc
test
lower
found
previou
studi
compar
pcr
demonstr
substanti
proport
patient
viru
infect
diagnos
correctli
within
two
hour
fact
specif
poct
rang
mean
almost
case
posit
test
result
correctli
rule
respiratori
viral
infect
howev
correct
identif
viral
infect
rule
bacteri
infect
limit
studi
address
detect
concurr
infect
bacteri
pathogen
diagnosi
bacteri
rti
notori
difficult
presenc
respiratori
bacteria
nasopharyng
swab
make
difficult
test
distinguish
infect
colon
sever
limit
studi
need
address
small
number
posit
find
certain
virus
ie
hmpv
hbov
piv
type
adenoviru
meant
could
calcul
sensit
poct
viru
includ
panel
although
includ
patient
number
suggest
initi
sampl
size
calcul
see
method
studi
respiratori
viru
preval
unfortun
lower
explain
wide
confid
interv
diagnost
accuraci
calcul
although
maripoc
multianalyt
rapid
test
avail
suitabl
pointofcar
assay
rti
primari
care
poct
would
ad
valu
viral
panel
test
also
includ
rhinovirus
frequent
detect
viru
anoth
limit
might
discrep
number
elig
patient
number
includ
patient
research
team
continu
motiv
gp
refer
patient
studi
particip
elig
patient
might
recruit
howev
compar
primari
care
studi
number
patient
includ
quit
high
probabl
fact
studi
perform
one
famili
practic
one
respiratori
season
studi
show
gp
patient
consid
diagnost
poct
respiratori
virus
valuabl
contribut
primari
care
implement
poct
could
help
confirm
presenc
viral
infect
posit
influenc
rate
antibiot
prescript
gp
netherland
possibl
also
countri
agreement
result
intern
survey
among
gp
indic
unmet
clinic
need
wide
access
rang
poct
assist
clinician
decis
especi
acut
condit
first
explor
interview
amongst
gp
reveal
posit
feedback
use
poct
appropri
qualit
survey
need
increas
insight
potenti
addit
valu
poct
primari
health
care
nevertheless
gp
consid
use
poct
care
diagnost
perform
antigen
test
depend
viral
load
sampl
turn
influenc
sever
ill
durat
symptom
shown
diagnost
test
sensit
estim
studi
falseneg
result
common
clinic
decis
make
test
result
therefor
alway
interpret
light
patient
medic
histori
physic
exam
studi
pave
road
assess
new
diagnost
opportun
rti
primari
health
care
confirm
find
assess
effect
poct
clinic
decis
make
determin
whether
use
poct
might
posit
affect
antibiot
prescript
rate
addit
studi
need
prefer
form
random
control
trial
besid
import
note
multifacet
intervent
reduc
overus
antibiot
effect
singl
initi
therefor
emphas
strategi
guid
antibiot
prescript
combin
encourag
develop
improv
poct
prefer
diagnost
poct
detect
virus
bacteria
combin
biomark
crp
summari
diagnost
poct
respiratori
virus
might
contribut
precis
evidencebas
diagnosi
rti
prospect
studi
determin
diagnost
perform
clinic
feasibl
maripoc
poct
detect
respiratori
virus
dutch
famili
practic
although
avail
poct
appreci
patient
gp
sensit
test
lower
expect
implement
diagnost
poct
primari
health
care
diagnost
accuraci
poct
need
improv
impact
poct
clinic
decis
make
assess
